IISc startup PathShodh gets regulatory approvals for COVID-19 Test

IISc startup PathShodh gets regulatory approvals for COVID-19 Test

IISc startup PathShodh gets regulatory approvals for COVID-19 Test PathShodh has received the license to manufacture the test for sale from the CDSCO, after due diligence validation at the Translational Health Science and THSTI, Faridabad, as per the requirements of the ICMR. PathShodh Healthcare, a startup incubated at the Society for Innovation and Development (SID)Read more about IISc startup PathShodh gets regulatory approvals for COVID-19 Test[…]

Indian Institute of Science develops new Covid-19 antibody test

Indian Institute of Science develops new Covid-19 antibody test

Indian Institute of Science develops new Covid-19 antibody test The IISc developed a semi-quantitative electrochemical ELISA test for Covid-19. The test can determine levels of Covid-induced IgM and IgG antibodies. The researchers at the Bengaluru-based Indian Institute of Science (IISc) have developed a new Covid-19 antibody test machine. The IISc developed a semi-quantitative electrochemical ELISARead more about Indian Institute of Science develops new Covid-19 antibody test[…]

IISc start-up gets regulatory approvals for new COVID-19 test

IISc start-up gets regulatory approvals for new COVID-19 test

IISc start-up gets regulatory approvals for new COVID-19 test A COVID-19 test developed by PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation (CDSCO). The test is touted toRead more about IISc start-up gets regulatory approvals for new COVID-19 test[…]

IISc developing oxygen concentrator, vaccine for Covid patients

IISc developing oxygen concentrator, vaccine for Covid patients

IISc developing oxygen concentrator, vaccine for Covid patients The premier Bengaluru-based Indian Institute of Science (IISc) is developing a low-cost oxygen concentrator and anti-Covid vaccine, Karnataka Health Minister K. Sudhakar said on Thursday. Bangalore: “IISc researchers are designing a low-cost and efficient oxygen concentrator and developing a vaccine for treating Covid patients,” said Sudhakar afterRead more about IISc developing oxygen concentrator, vaccine for Covid patients[…]

Time2

Time2

It isn’t just the large players and corporations or the exciting startups that are central to the economy of the future. Infact, between these two poles, the large and significant sea of manufacturing, medium sized and smaller enterprises lie. Here there is already a degree of competence in manufacturing, distribution, marketing etc. and often theRead more about Time<sup>2</sup>[…]

philanthropy

philanthropy

IF THERE EVER WAS A TIME FOR PROACTIVE PHILANTHROPY IN THE WORLD, IT IS NOW. Not just ‘patchwork’ philanthropy, based only on charitable grants, but a new model that creates a virtuous cascade of economic enrichment. The reason why we became an ‘Innovation Philanthropy’ We believe that innovation that is founded on deep science andRead more about philanthropy[…]

tatpar

tatpar

During these pressing times of the Pandemic, we supported the development of several lifesaving rapid response technologies that deploy deep science in the service of humanity, under the TATPAR scheme. The products are at different stages of development and we are actively seeking a spectrum of partners to rapidly reach it to the world atRead more about tatpar[…]

leader_1

leader_1

Prof. Govindan Rangarajan Director, Indian Institute of Science (IISc) Bengaluru,(Principle Investigator)